Pharmidex Exhibiting at ERS International Congress 2018
September 12, 2018

Pharmidex will be exhibiting at the up coming ERS conference.

ERS International Congress Paris 2018. 



The conference will be taking place from the 16th to the 19th of September. Please Feel free to visit the Pharmidex team at booth K.38 which is located on the 1st floor of the congress center.


Covering key topics in respiratory medicine from across the spectrum of disease areas including TB, lung cancer, chronic and acute respiratory failure, sleep breathing disorders, interstitial lung diseases, pneumonia, cystic fibrosis, COPD and asthma, amongst others, the Congress programme is set to deliver the best advances in both science and education.


This Congress will specifically highlight the importance of environment in respiratory health and focus on the need to personalise medicine in the respiratory arena. Special attention will also be paid to our interactions with microorganisms in our environment as well as those that live in peace within our organism.


We look forward to welcoming you to the ERS International Congress where we will continue our mission to promote lung health and drive standards in respiratory medicine, in close partnership with national societies, patient organisations, and various institutions all over Europe and beyond.

We’re Hiring! Senior/Principal Scientist–In Vivo Pharmacologist
July 30, 2025
We’re Hiring! Senior/Principal Scientist–In Vivo Pharmacologist
July 28, 2025
We’re delighted to welcome Gabrielle Georgiou and Dr. Mohammed Ahmad from the University of Hertfordshire as they begin their first experience in a scientific CRO environment here at Pharmidex ! This partnership is an exciting step in fostering early-career scientific talent by offering hands-on exposure to real-world drug discovery and preclinical research. A big thank you to the University of Hertfordshire for partnering with us to support the next generation of innovators. We’re proud to play a role in shaping future leaders in science through meaningful, practical learning opportunities. 👩‍🔬 👨‍🔬 Welcome to the team, Gabrielle and Mohammed!
BATA Taste Aversion
July 24, 2025
At Pharmidex , we offer Brief Access Taste Aversion (BATA) testing, which is a behavioural assay that quantifies how test subjects respond to different compounds or formulations by measuring lick response and aversion. This helps identify: ✅ Bitter-tasting APIs ✅ Unpalatable excipients ✅ The success of taste-masking strategies ✅ Formulation-dependent compliance risks Get in touch if you’re developing oral formulations, paediatric drugs, or repurposing bitter APIs, this could be the data your IND package needs.
More Posts